Regulatory Considerations for Combined Drug-Device Studies in Europe: A Case Study Involving Bile Sampling.

Podhaisky HP, Tsuruta E, Piel I, Otto C, Paez SB, Font-Nieves M

Open source

DOI
10.1007/s40290-026-00619-9
Published
2026 Sep
Container
Pharmaceutical medicine
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40290-026-00619-9,
  title = {Regulatory Considerations for Combined Drug-Device Studies in Europe: A Case Study Involving Bile Sampling.},
  author = {Podhaisky HP and Tsuruta E and Piel I and Otto C and Paez SB and Font-Nieves M},
  year = {2026},
  journal = {Pharmaceutical medicine},
  doi = {10.1007/s40290-026-00619-9},
  url = {https://doi.org/10.1007/s40290-026-00619-9}
}

RIS

TY  - JOUR
TI  - Regulatory Considerations for Combined Drug-Device Studies in Europe: A Case Study Involving Bile Sampling.
AU  - Podhaisky HP
AU  - Tsuruta E
AU  - Piel I
AU  - Otto C
AU  - Paez SB
AU  - Font-Nieves M
PY  - 2026
JO  - Pharmaceutical medicine
DO  - 10.1007/s40290-026-00619-9
UR  - https://doi.org/10.1007/s40290-026-00619-9
ER  - 

APA

HP, P., E, T., I, P., C, O., SB, P., & M, F. (2026). Regulatory Considerations for Combined Drug-Device Studies in Europe: A Case Study Involving Bile Sampling.. Pharmaceutical medicine. https://doi.org/10.1007/s40290-026-00619-9

Source records